DE973095C
(de)
|
1955-01-19 |
1959-12-03 |
Kalle & Co Ag |
Verfahren zur UEberfuehrung von OElen in streufaehige Pulver durch Spruehtrocknung von OEl-in-Wasser-Emulsionen
|
HU176101B
(en)
|
1977-12-29 |
1980-12-28 |
Gyogyszerkutato Intezet |
Process for producing bis-bracket-nitrozo-ureido-bracket closed-polyol derivatives
|
DE3013839A1
(de)
|
1979-04-13 |
1980-10-30 |
Freunt Ind Co Ltd |
Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
FR2525108B1
(fr)
|
1982-04-19 |
1989-05-12 |
Elan Corp Ltd |
Medicaments a haut degre de solubilite et procede pour leur obtention
|
US4769235A
(en)
|
1984-01-27 |
1988-09-06 |
New York University |
Immunodominant epitope of the circumsporozoite surface protein
|
US4629621A
(en)
*
|
1984-07-23 |
1986-12-16 |
Zetachron, Inc. |
Erodible matrix for sustained release bioactive composition
|
US4590065A
(en)
*
|
1985-04-18 |
1986-05-20 |
Colgate-Palmolive Company |
Stable flavor-containing dentifrice
|
US4758427A
(en)
|
1985-08-08 |
1988-07-19 |
Ciba-Geigy Corporation |
Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
|
PH22025A
(en)
|
1985-08-19 |
1988-05-13 |
Johnson & Son Inc S C |
Aqueous pyrethroid insecticidal formulations and method of increasing the stability thereof
|
DE3612212A1
(de)
*
|
1986-04-11 |
1987-10-15 |
Basf Ag |
Verfahren zur herstellung von festen pharmazeutischen formen
|
DE3612211A1
(de)
|
1986-04-11 |
1987-10-15 |
Basf Ag |
Kontinuierliches verfahren zum tablettieren
|
DE3682208D1
(de)
*
|
1986-12-18 |
1991-11-28 |
Kurt Heinz Bauer |
Gegenueber lichteinfluss stabilisiertes nifedipin-konzentrat und verfahren zu seiner herstellung.
|
US4804699A
(en)
*
|
1987-05-15 |
1989-02-14 |
Ici Americas Inc. |
Monomeric and oligomeric glutarate-based light stabilizers for plastics
|
US5756450A
(en)
|
1987-09-15 |
1998-05-26 |
Novartis Corporation |
Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
|
IL87710A
(en)
*
|
1987-09-18 |
1992-06-21 |
Ciba Geigy Ag |
Covered floating retard form for controlled release in gastric juice
|
AU2902289A
(en)
|
1987-12-08 |
1989-07-05 |
Mark Chasin |
Method of forming bioerodible implants for improved controlled drug release
|
DE3812567A1
(de)
|
1988-04-15 |
1989-10-26 |
Basf Ag |
Verfahren zur herstellung pharmazeutischer mischungen
|
DE3830353A1
(de)
|
1988-09-07 |
1990-03-15 |
Basf Ag |
Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
|
DE3830733A1
(de)
|
1988-09-09 |
1990-03-22 |
Basf Ag |
5-(n-3,4,5,6-tetrahydrophthalimido)-zimtsaeurederivate, ihre herstellung und ihre verwendung in herbiziden mitteln
|
US5368864A
(en)
|
1988-11-25 |
1994-11-29 |
Henning Berlin Gmbh Chemie- Und Pharmawerk |
Formulation of oxypurinol and/or its alkali and alkaline earth salts
|
DE3839825A1
(de)
|
1988-11-25 |
1990-06-13 |
Henning Berlin Gmbh |
Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze
|
GB8903328D0
(en)
|
1989-02-14 |
1989-04-05 |
Ethical Pharma Ltd |
Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
|
US5552558A
(en)
|
1989-05-23 |
1996-09-03 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
US5354866A
(en)
|
1989-05-23 |
1994-10-11 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
HU204529B
(en)
|
1989-08-10 |
1992-01-28 |
Richter Gedeon Vegyeszet |
Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
|
US5075291A
(en)
|
1989-11-22 |
1991-12-24 |
Ici Americas Inc. |
Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound
|
JPH07501259A
(ja)
*
|
1990-06-01 |
1995-02-09 |
リサーチ コーポレイション テクノロジーズ,インコーポレイテッド |
自己乳化型ガラス
|
SE9003296L
(sv)
|
1990-10-16 |
1992-04-17 |
Kabi Pharmacia Ab |
Foerfarande foer att formulera laekemedel
|
AU1537292A
(en)
|
1991-04-16 |
1992-11-17 |
Nippon Shinyaku Co. Ltd. |
Method of manufacturing solid dispersion
|
WO1993007859A1
(en)
|
1991-10-23 |
1993-04-29 |
Warner-Lambert Company |
Novel pharmaceutical pellets and process for their production
|
DE4138513A1
(de)
|
1991-11-23 |
1993-05-27 |
Basf Ag |
Feste pharmazeutische retardform
|
US5290351A
(en)
|
1991-12-09 |
1994-03-01 |
Ritter Robert A |
Composition for rendering waste substances harmless
|
CA2124821C
(en)
|
1991-12-18 |
2003-10-07 |
Isaac Ghebre-Sellassie |
Novel solid pharmaceutical dispersions
|
DE4200821A1
(de)
|
1992-01-15 |
1993-07-22 |
Bayer Ag |
Geschmacksmaskierte pharmazeutische mittel
|
DE4201179A1
(de)
*
|
1992-01-17 |
1993-07-22 |
Alfatec Pharma Gmbh |
Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
|
EP0626850B1
(en)
|
1992-02-18 |
2002-05-15 |
Pharmos Corporation |
Dry compositions for preparing submicron emulsions
|
US5654003A
(en)
|
1992-03-05 |
1997-08-05 |
Fuisz Technologies Ltd. |
Process and apparatus for making tablets and tablets made therefrom
|
ZA932268B
(en)
|
1992-03-30 |
1993-11-11 |
Alza Corp |
Polymer system containing a partially soluble compound
|
CA2095776C
(en)
*
|
1992-05-12 |
2007-07-10 |
Richard C. Fuisz |
Rapidly dispersable compositions containing polydextrose
|
US5281420A
(en)
|
1992-05-19 |
1994-01-25 |
The Procter & Gamble Company |
Solid dispersion compositions of tebufelone
|
IT1256026B
(it)
|
1992-06-12 |
1995-11-20 |
|
Sali del glutatione etilestere
|
DE4220782A1
(de)
*
|
1992-06-25 |
1994-01-05 |
Basf Ag |
Verfahren zur Herstellung von festen pharmazeutischen Retardformen
|
DE4226753A1
(de)
|
1992-08-13 |
1994-02-17 |
Basf Ag |
Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen
|
CA2147283C
(en)
|
1992-10-16 |
2007-01-16 |
Kouichi Nakamichi |
Method of manufacturing wax matrices
|
JPH08506081A
(ja)
*
|
1993-02-12 |
1996-07-02 |
ファーモス コーポレイション |
サブミクロン・エマルジョンの調製のための乾燥組成物
|
GB9306887D0
(en)
|
1993-04-01 |
1993-05-26 |
Graham Neil B |
Random block copolymers
|
DE4316537A1
(de)
*
|
1993-05-18 |
1994-11-24 |
Basf Ag |
Zubereitungen in Form fester Lösungen
|
DE69428707T2
(de)
|
1993-08-20 |
2002-07-11 |
Nippon Shinyaku Co Ltd |
Im magen verbleibende zubereitung, quellender formkörper und herstellungsverfahren
|
US5773025A
(en)
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
IL110752A
(en)
*
|
1993-09-13 |
2000-07-26 |
Abbott Lab |
Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
|
US5559158A
(en)
*
|
1993-10-01 |
1996-09-24 |
Abbott Laboratories |
Pharmaceutical composition
|
JPH09510182A
(ja)
*
|
1993-11-17 |
1997-10-14 |
エルディーエス・テクノロジーズ・インコーポレーテッド |
カプセル封入されたドラッグデリバリー用透明液
|
KR100354702B1
(ko)
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
ES2199981T3
(es)
|
1994-02-16 |
2004-03-01 |
Abbott Laboratories |
Modo de preparacion de formulaciones farmaceuticas de particulas finas.
|
WO1995022962A1
(en)
|
1994-02-23 |
1995-08-31 |
Bm Research A/S |
Controlled release composition
|
DE4413350A1
(de)
*
|
1994-04-18 |
1995-10-19 |
Basf Ag |
Retard-Matrixpellets und Verfahren zu ihrer Herstellung
|
DE19509807A1
(de)
*
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
|
US5443178A
(en)
|
1994-06-23 |
1995-08-22 |
Allergan, Inc. |
Tablet dispensing system
|
FR2722984B1
(fr)
|
1994-07-26 |
1996-10-18 |
Effik Lab |
Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
|
EP0800385B1
(en)
|
1994-09-30 |
2000-12-20 |
Takeda Chemical Industries, Ltd. |
Oral sustained-release preparation
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
DE4446468A1
(de)
|
1994-12-23 |
1996-06-27 |
Basf Ag |
Verfahren zur Herstellung von umhüllten Tabletten
|
DE4446470A1
(de)
*
|
1994-12-23 |
1996-06-27 |
Basf Ag |
Verfahren zur Herstellung von teilbaren Tabletten
|
DE4446467A1
(de)
|
1994-12-23 |
1996-06-27 |
Basf Ag |
Verfahren zur Herstellung von linsenförmigen Tabletten durch Schmelzkalandrierung
|
US5545628A
(en)
|
1995-01-10 |
1996-08-13 |
Galephar P.R. Inc. |
Pharmaceutical composition containing fenofibrate
|
DE19500977C2
(de)
|
1995-01-14 |
1999-01-07 |
Lohmann Therapie Syst Lts |
Feste Arzneimittelform mit in polymerem Material verteiltem Wirkstoff
|
NZ270439A
(en)
|
1995-02-02 |
1996-04-26 |
Bernard Charles Sherman |
Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
|
DE19504832A1
(de)
|
1995-02-14 |
1996-08-22 |
Basf Ag |
Feste Wirkstoff-Zubereitungen
|
DE19509806A1
(de)
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Lagerstabile Arzneiformen
|
DE19509805A1
(de)
*
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
|
DE69634246T2
(de)
|
1995-04-14 |
2006-01-12 |
Nektar Therapeutics, San Carlos |
Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit
|
SI9500173B
(sl)
|
1995-05-19 |
2002-02-28 |
Lek, |
Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
|
US5567823A
(en)
|
1995-06-06 |
1996-10-22 |
Abbott Laboratories |
Process for the preparation of an HIV protease inhibiting compound
|
SE9502244D0
(sv)
|
1995-06-20 |
1995-06-20 |
Bioglan Ab |
A composition and a process for the preparation thereof
|
US6037157A
(en)
*
|
1995-06-29 |
2000-03-14 |
Abbott Laboratories |
Method for improving pharmacokinetics
|
BE1009856A5
(fr)
*
|
1995-07-14 |
1997-10-07 |
Sandoz Sa |
Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
|
TW487582B
(en)
|
1995-08-11 |
2002-05-21 |
Nissan Chemical Ind Ltd |
Method for converting sparingly water-soluble medical substance to amorphous state
|
AU6824996A
(en)
*
|
1995-08-17 |
1997-03-12 |
Dyer, Alison Margaret |
Controlled release products
|
DE19531277A1
(de)
*
|
1995-08-25 |
1997-02-27 |
Basf Ag |
Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
|
US6391338B1
(en)
*
|
1995-09-07 |
2002-05-21 |
Biovail Technologies Ltd. |
System for rendering substantially non-dissoluble bio-affecting agents bio-available
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
DE19536394A1
(de)
*
|
1995-09-29 |
1997-04-03 |
Basf Ag |
Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze
|
DE19536387A1
(de)
|
1995-09-29 |
1997-04-03 |
Basf Ag |
Verfahren zur Herstellung von vitaminhaltigen festen Zubereitungen
|
WO1997013503A1
(en)
|
1995-10-13 |
1997-04-17 |
The Penn State Research Foundation |
Synthesis of drug nanoparticles by spray drying
|
DE19539361A1
(de)
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
|
DE19539360A1
(de)
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von festen Arzneiformen
|
DE19539363A1
(de)
|
1995-10-23 |
1997-04-24 |
Basf Ag |
Verfahren zur Herstellung von festen Arzneiformen
|
DE19539574A1
(de)
|
1995-10-25 |
1997-04-30 |
Boehringer Mannheim Gmbh |
Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
|
US5914332A
(en)
|
1995-12-13 |
1999-06-22 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
US5858401A
(en)
*
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
DE19602206A1
(de)
|
1996-01-23 |
1997-07-24 |
Basf Ag |
Zubereitungen nichtsteroidaler Analgetika
|
US5762961A
(en)
|
1996-02-09 |
1998-06-09 |
Quadrant Holdings Cambridge Ltd. |
Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
|
US5958455A
(en)
|
1996-02-09 |
1999-09-28 |
Quadrant Holdings Cambridge Ltd |
Oral solid dosage forms, methods of making same and compositions thereof
|
US20030064108A1
(en)
*
|
1996-04-23 |
2003-04-03 |
Stefan Lukas |
Taste masked pharmaceutical compositions
|
DE19617716A1
(de)
|
1996-05-03 |
1997-11-06 |
Basf Ag |
In wäßriger Lösung redispergierbare Polymerpulver
|
TR199801225T2
(xx)
|
1996-05-20 |
1998-11-23 |
Janssen Pharmaceutica N.V. |
Geli�tirilmi� biyolojik kullan�l�rl��a sahip antifungal bile�imler.
|
US5834472A
(en)
|
1996-05-24 |
1998-11-10 |
Schering Corporation |
Antifungal composition with enhanced bioavailability
|
SK281818B6
(sk)
|
1996-05-24 |
2001-08-06 |
Schering Corporation |
Farmaceutický prostriedok obsahujúci fungicídne činidlo
|
US6764690B2
(en)
|
1996-05-29 |
2004-07-20 |
Delsitech Oy |
Dissolvable oxides for biological applications
|
AU3146997A
(en)
|
1996-06-03 |
1998-01-05 |
Merck & Co., Inc. |
Pediatric formulation for hiv protease inhibitors
|
US5935936A
(en)
|
1996-06-03 |
1999-08-10 |
Genzyme Corporation |
Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
|
DE19624607A1
(de)
|
1996-06-20 |
1998-01-02 |
Basf Ag |
Verfahren zur Herstellung von Salzen von Säuregruppen tragenden pharmazeutischen Wirkstoffen
|
ES2325046T3
(es)
|
1996-06-26 |
2009-08-24 |
The Board Of Regents, The University Of Texas System |
Formulacion farmaceutica extruible por fusion en caliente.
|
DE19629753A1
(de)
*
|
1996-07-23 |
1998-01-29 |
Basf Ag |
Verfahren zur Herstellung von festen Arzneiformen
|
DE19635676A1
(de)
|
1996-09-03 |
1998-03-05 |
Basf Ag |
Feste geschäumte Wirkstoffzubereitungen
|
DE19637479A1
(de)
|
1996-09-13 |
1998-03-19 |
Basf Ag |
Verfahren zur Herstellung fester pharmazeutischer Formen
|
TW474824B
(en)
*
|
1996-09-13 |
2002-02-01 |
Basf Ag |
The production of solid pharmaceutical forms
|
US6488961B1
(en)
|
1996-09-20 |
2002-12-03 |
Ethypharm, Inc. |
Effervescent granules and methods for their preparation
|
US6649186B1
(en)
|
1996-09-20 |
2003-11-18 |
Ethypharm |
Effervescent granules and methods for their preparation
|
US6071539A
(en)
|
1996-09-20 |
2000-06-06 |
Ethypharm, Sa |
Effervescent granules and methods for their preparation
|
US5727878A
(en)
*
|
1996-10-17 |
1998-03-17 |
Cdf Corporation |
Liner for a mixing container and an assembly and method for mixing fluid components
|
US8828432B2
(en)
*
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
US20010006677A1
(en)
|
1996-10-29 |
2001-07-05 |
Mcginity James W. |
Effervescence polymeric film drug delivery system
|
KR20000053276A
(ko)
|
1996-11-15 |
2000-08-25 |
플레믹 크리스티안 |
성형 또는 비성형 폴리올 물질의 제조 방법
|
US6232333B1
(en)
*
|
1996-11-21 |
2001-05-15 |
Abbott Laboratories |
Pharmaceutical composition
|
FR2756736B1
(fr)
|
1996-12-05 |
1999-03-05 |
Sanofi Sa |
Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
|
TW486370B
(en)
|
1996-12-25 |
2002-05-11 |
Yamanouchi Pharma Co Ltd |
Rapidly disintegrable pharmaceutical composition
|
US6045829A
(en)
*
|
1997-02-13 |
2000-04-04 |
Elan Pharma International Limited |
Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
|
DE19709663A1
(de)
*
|
1997-03-10 |
1998-09-17 |
Basf Ag |
Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen
|
DE19710009A1
(de)
|
1997-03-12 |
1998-09-24 |
Knoll Ag |
Mehrphasige wirkstoffhaltige Zubereitungsformen
|
DE19710213A1
(de)
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Verfahren zur Herstellung von festen Kombinationsarzneiformen
|
US5948426A
(en)
|
1997-05-03 |
1999-09-07 |
Jefferies; Steven R. |
Method and article to induce hematopoietic expansion
|
US6610764B1
(en)
|
1997-05-12 |
2003-08-26 |
Metabolix, Inc. |
Polyhydroxyalkanoate compositions having controlled degradation rates
|
DE19721467A1
(de)
|
1997-05-22 |
1998-11-26 |
Basf Ag |
Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
|
GB9710699D0
(en)
*
|
1997-05-24 |
1997-07-16 |
Danbiosyst Uk |
Gastro-retentive controlled release system
|
DE19727649C2
(de)
*
|
1997-06-28 |
1999-12-16 |
Didier Werke Ag |
Keramischer Verbundkörper und dessen Verwendungen
|
US5955475A
(en)
|
1997-06-30 |
1999-09-21 |
Endo Pharmaceuticals Inc. |
Process for manufacturing paroxetine solid dispersions
|
US5889051A
(en)
*
|
1997-07-15 |
1999-03-30 |
Development Center For Biotechnology |
Stabilization of prostaglandin drug
|
DE19733505A1
(de)
|
1997-08-01 |
1999-02-04 |
Knoll Ag |
Schnell wirksames Analgeticum
|
ES2287971T3
(es)
|
1997-08-11 |
2007-12-16 |
Pfizer Products Inc. |
Dispersiones farmaceuticas solidas con biodisponibilidad incrementada.
|
HN1998000115A
(es)
|
1997-08-21 |
1999-06-02 |
Warner Lambert Co |
Formas de dosificación farmacéuticas sólidas
|
DE69828635T2
(de)
*
|
1997-09-19 |
2005-06-16 |
Shire Laboratories, Inc. |
Feste lösungskügelchen
|
JP3460538B2
(ja)
*
|
1997-10-08 |
2003-10-27 |
救急薬品工業株式会社 |
速溶性フィルム製剤
|
US20020164374A1
(en)
|
1997-10-29 |
2002-11-07 |
John Jackson |
Polymeric systems for drug delivery and uses thereof
|
US6027747A
(en)
*
|
1997-11-11 |
2000-02-22 |
Terracol; Didier |
Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
|
ES2174538T3
(es)
*
|
1997-11-28 |
2002-11-01 |
Knoll Ag |
Procedimiento para la obtencion de substancias exentas de disolventes, no cristalinas, biologicamente activas.
|
DE19753298A1
(de)
*
|
1997-12-01 |
1999-06-02 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
US6632455B2
(en)
|
1997-12-22 |
2003-10-14 |
Schering Corporation |
Molecular dispersion composition with enhanced bioavailability
|
GB9802088D0
(en)
|
1998-01-30 |
1998-03-25 |
Scherer Ltd R P |
Pharmaceutical products
|
US6787157B1
(en)
|
1998-03-10 |
2004-09-07 |
Abbott Laboratories |
Multiphase active ingredient-containing formulations
|
KR100655627B1
(ko)
*
|
1998-03-16 |
2006-12-12 |
아스텔라스세이야쿠 가부시키가이샤 |
구강 내에서 급속히 붕괴되는 정제
|
DE19812688A1
(de)
*
|
1998-03-23 |
1999-09-30 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
DE19814739A1
(de)
|
1998-04-02 |
1999-10-07 |
Basf Ag |
Verwendung von Polyalkylenoxid-haltigen Pfropfpolymerisaten als Solubilisatoren
|
US5945123A
(en)
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
US20040062802A1
(en)
*
|
1998-04-02 |
2004-04-01 |
Hermelin Victor M. |
Maximizing effectiveness of substances used to improve health and well being
|
DE19814730A1
(de)
|
1998-04-02 |
1999-10-07 |
Basf Ag |
Verwendung von N-Vinyllacram oder N-Vinylamin haltigen Copolymeren als Matrix zur Herstellung von festen pharmazeutischen und kosmetischen Darreichungsformen
|
KR20010042536A
(ko)
|
1998-04-08 |
2001-05-25 |
히라타 다다시 |
정제의 제조방법 및 정제
|
JP2003526694A
(ja)
|
1998-04-24 |
2003-09-09 |
イーストマン ケミカル カンパニー |
セルロースエステルと機能性添加剤との共沈及びそれによって得られる組成物
|
JP4027535B2
(ja)
|
1998-05-26 |
2007-12-26 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
脂溶性薬物を含有した粉末
|
EP1082026A1
(en)
|
1998-06-05 |
2001-03-14 |
Forbes Medi-Tech Inc. |
Compositions comprising phytosterol and/or phytostanol having enhenced solubility and dispersa
|
EP1003485A1
(en)
|
1998-06-11 |
2000-05-31 |
Em Industries, Inc. |
Micro-osmotic controlled drug delivery systems
|
KR100336090B1
(ko)
*
|
1998-06-27 |
2002-05-27 |
윤승원 |
오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
|
US6894171B1
(en)
*
|
1998-07-20 |
2005-05-17 |
Abbott Laboratories |
Polymorph of a pharmaceutical
|
US20010021372A1
(en)
|
1998-08-18 |
2001-09-13 |
Tore Omtveit |
Apparatus having partially gold-plated surface
|
DE19839276A1
(de)
|
1998-08-28 |
2000-03-02 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
DE19840256A1
(de)
*
|
1998-09-03 |
2000-03-09 |
Basf Ag |
Verfahren zur Herstellung von beschichteten festen Dosierungsformen
|
DE19841244A1
(de)
|
1998-09-09 |
2000-03-16 |
Knoll Ag |
Verfahren und Vorrichtung zum Herstellen von Tabletten
|
DE19842753A1
(de)
|
1998-09-18 |
2000-03-23 |
Bayer Ag |
Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
|
DE19842914A1
(de)
|
1998-09-18 |
2000-03-23 |
Basf Ag |
Testsystem zur Charakterisierung der Verträglichkeit von biologisch aktiven Substanzen und Polyvinylpyrrolidon
|
DE19843904A1
(de)
|
1998-09-24 |
2000-03-30 |
Basf Ag |
Feste Dosierungsform mit polymerem Bindemittel
|
US20040013613A1
(en)
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
DE19847618A1
(de)
|
1998-10-15 |
2000-04-20 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
US6502135B1
(en)
|
1998-10-30 |
2002-12-31 |
Science Applications International Corporation |
Agile network protocol for secure communications with assured system availability
|
DE19853985A1
(de)
*
|
1998-11-23 |
2000-05-25 |
Basf Ag |
Verfahren zur Herstellung von festen Dosierungsformen
|
DE19855440A1
(de)
|
1998-12-01 |
2000-06-08 |
Basf Ag |
Verfahren zum Herstellen fester Darreichungsformen mittels Schmelzextrusion
|
DE19856147A1
(de)
|
1998-12-04 |
2000-06-08 |
Knoll Ag |
Teilbare feste Dosierungsformen und Verfahren zu ihrer Herstellung
|
DE19856432A1
(de)
*
|
1998-12-08 |
2000-06-15 |
Basf Ag |
Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
|
AT407111B
(de)
*
|
1998-12-22 |
2000-12-27 |
Gergely Dr & Co |
Zucker- und/oder zuckeralkoholhältiges matrixmaterial und verfahren zu seiner herstellung
|
EP1058539A1
(en)
|
1999-01-06 |
2000-12-13 |
Korea Research Institute Of Chemical Technology |
Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same
|
DE19901383A1
(de)
|
1999-01-15 |
2000-07-20 |
Knoll Ag |
Verfahren zur Herstellung unterschiedlicher fester Dosierungsformen
|
ES2310164T3
(es)
|
1999-02-10 |
2009-01-01 |
Pfizer Products Inc. |
Dispositivo de liberacion controlada por la matriz.
|
US6706283B1
(en)
*
|
1999-02-10 |
2004-03-16 |
Pfizer Inc |
Controlled release by extrusion of solid amorphous dispersions of drugs
|
ATE400252T1
(de)
|
1999-02-10 |
2008-07-15 |
Pfizer Prod Inc |
Pharmazeutische feste dispersionen
|
US6440946B1
(en)
|
1999-02-25 |
2002-08-27 |
Takeda Chemical Industries, Ltd. |
Multiple-agents-binding compound, production and use thereof
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
DE19911097A1
(de)
|
1999-03-12 |
2000-09-14 |
Basf Ag |
Verfahren zur Herstellung von festen cyclodextrinhaltigen Dosierungsformen
|
DK1163234T3
(da)
*
|
1999-03-24 |
2006-02-27 |
Scherer Technologies Inc R P |
Farmaceutiske formuleringer med forbedret vandoplöselighed
|
DE19913692A1
(de)
*
|
1999-03-25 |
2000-09-28 |
Basf Ag |
Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
|
DE19913606A1
(de)
|
1999-03-25 |
2000-09-28 |
Basf Ag |
Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
|
US6383471B1
(en)
*
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
FR2793689B1
(fr)
*
|
1999-05-19 |
2001-08-24 |
Pf Medicament |
Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
|
US7919119B2
(en)
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6465011B2
(en)
|
1999-05-29 |
2002-10-15 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
NL1012300C2
(nl)
|
1999-06-11 |
2000-12-12 |
Rijksuniversiteit |
Stabilisator voor farmaca.
|
DE19929361A1
(de)
|
1999-06-25 |
2001-01-04 |
Basf Ag |
Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
|
FR2795326B1
(fr)
|
1999-06-28 |
2001-08-31 |
Adir |
Composition pharmaceutique solide thermoformable a liberation controlee
|
DE19930454A1
(de)
|
1999-07-02 |
2001-01-04 |
Knoll Ag |
Feste Paroxetin enthaltende Zubereitungen
|
DE19934610A1
(de)
*
|
1999-07-23 |
2001-01-25 |
Bayer Ag |
Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
|
US6284270B1
(en)
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
DE19943501A1
(de)
|
1999-09-10 |
2001-03-15 |
Basf Ag |
Unterwassergranulation wirkstoffhaltiger Schmelzen
|
SE9903236D0
(sv)
|
1999-09-10 |
1999-09-10 |
Astra Ab |
Method to obtain microparticles
|
DE19945982A1
(de)
|
1999-09-24 |
2001-03-29 |
Knoll Ag |
Geschwindigkeitsbestimmte Partikel
|
AU775360B2
(en)
|
1999-09-24 |
2004-07-29 |
Janssen Pharmaceutica N.V. |
Antiviral compositions
|
ES2288872T3
(es)
|
1999-09-29 |
2008-02-01 |
R.P. Scherer Technologies, Inc. |
Granulaciones con celulosa hidrolizada de sales de medicamentos.
|
DE19949897A1
(de)
|
1999-10-15 |
2001-04-19 |
Rainer Rogasch |
Formkörper und Verfahren zu dessen Herstellung
|
US6264981B1
(en)
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
US6372259B1
(en)
*
|
1999-11-10 |
2002-04-16 |
University Of Iowa Research Foundation |
Palatable, sustained release drug granules
|
ATE329579T1
(de)
|
1999-11-12 |
2006-07-15 |
Abbott Lab |
Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
|
DE60017444T2
(de)
|
1999-11-12 |
2006-02-09 |
Abbott Laboratories, Abbott Park |
Pharmazeutische formulierungen auf basis fester dispersionen
|
DE19958007A1
(de)
|
1999-12-02 |
2001-06-07 |
Roehm Gmbh |
Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen
|
DE19960494A1
(de)
*
|
1999-12-15 |
2001-06-21 |
Knoll Ag |
Vorrichtung und Verfahren zum Herstellen von festen wirkstoffhaltigen Formen
|
DE19961334A1
(de)
|
1999-12-17 |
2001-06-21 |
Roehm Gmbh |
Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere
|
CA2395331C
(en)
*
|
1999-12-23 |
2009-01-06 |
Pfizer Products Inc. |
Pharmaceutical compositions providing enhanced drug concentrations
|
US20020015731A1
(en)
|
1999-12-23 |
2002-02-07 |
Appel Leah E. |
Hydrogel-Driven Drug Dosage Form
|
CA2396380C
(en)
|
1999-12-23 |
2015-04-21 |
David Hayes |
Improved pharmaceutical compositions for poorly soluble drugs
|
US6380398B2
(en)
*
|
2000-01-04 |
2002-04-30 |
Novo Nordisk A/S |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
DE10000792A1
(de)
|
2000-01-11 |
2001-07-19 |
Bernhard C Lippold |
Formulierungen von Wirkstoffen in Form einer festen Dispersion
|
US7029700B2
(en)
|
2000-01-14 |
2006-04-18 |
Brown University Research Foundation |
Micronized freeze-dried particles
|
TW449928B
(en)
*
|
2000-01-25 |
2001-08-11 |
Samsung Electronics Co Ltd |
A low temperature polycrystalline silicon type thin film transistor and a method of the thin film transistor fabrication
|
GB0003782D0
(en)
*
|
2000-02-17 |
2000-04-05 |
Dumex Ltd As |
Process
|
GB0005016D0
(en)
|
2000-03-01 |
2000-04-26 |
Jumik Technologies Limited |
PVA-Containing compositions
|
JP2003525895A
(ja)
|
2000-03-09 |
2003-09-02 |
アストラゼネカ・アクチエボラーグ |
固形分散剤の製造方法
|
US20010053791A1
(en)
|
2000-03-16 |
2001-12-20 |
Babcock Walter C. |
Glycogen phosphorylase inhibitor
|
DE10013289A1
(de)
|
2000-03-17 |
2001-09-20 |
Knoll Ag |
Torasemid enthaltende pharmazeutische Zubereitungen
|
DE10015479A1
(de)
|
2000-03-29 |
2001-10-11 |
Basf Ag |
Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
|
US6608198B2
(en)
|
2000-03-30 |
2003-08-19 |
Abbott Laboratories |
Crystalline pharmaceutical
|
GB0008785D0
(en)
|
2000-04-10 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
DE10021539C1
(de)
|
2000-05-03 |
2002-02-28 |
Henkel Kgaa |
Vorrichtung zur Sprühtrocknung von lösungsmittelhaltigen Zusammensetzungen
|
US20020001617A1
(en)
*
|
2000-05-26 |
2002-01-03 |
Chang-Hyun Lee |
Rapidly disintegrating tablet and process for the manufacture thereof
|
DE10026698A1
(de)
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
DE10026699A1
(de)
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage
|
DE10029201A1
(de)
|
2000-06-19 |
2001-12-20 |
Basf Ag |
Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
|
US20100010101A1
(en)
*
|
2000-07-05 |
2010-01-14 |
Capricorn Pharma, Inc. |
Rapid-Melt Compositions and Methods of Making Same
|
US6375982B1
(en)
|
2000-07-05 |
2002-04-23 |
Capricorn Pharma, Inc. |
Rapid-melt semi-solid compositions, methods of making same and method of using same
|
AU2001279284A1
(en)
|
2000-07-05 |
2002-01-14 |
Capricorn Pharma, Inc |
Rapid-melt semi-solid compositions, methods of making same and methods of using same
|
IT1318618B1
(it)
|
2000-07-10 |
2003-08-27 |
A C R Applied Coating Res S A |
Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
|
AU2001289653A1
(en)
|
2000-07-14 |
2002-01-30 |
Universiteit Gent |
Composite solid shaped articles for the controlled delivery of biologically active ingredients
|
DE10038571A1
(de)
*
|
2000-08-03 |
2002-02-14 |
Knoll Ag |
Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen
|
EP1308156A4
(en)
|
2000-08-11 |
2009-07-15 |
Eisai R&D Man Co Ltd |
AGGREGATE SOLID DISPERSION WITH IMPROVED SOLUBILITY
|
US6372905B1
(en)
*
|
2000-08-31 |
2002-04-16 |
Abbott Laboratories |
Processes and intermediates for preparing retroviral protease inhibitors
|
DE10046541A1
(de)
*
|
2000-09-19 |
2002-03-28 |
Knoll Ag |
Mechanisch stabile darreichungsformen, enthaltend Ubichinone
|
FR2814366A1
(fr)
*
|
2000-09-22 |
2002-03-29 |
Rhodia Chimie Sa |
Procede de granulation de matieres actives par extrusion basse pression pour l'obtention de granules directement compressibles
|
WO2002024168A1
(fr)
|
2000-09-25 |
2002-03-28 |
Nippon Shinyaku Co., Ltd. |
Procede de production d'une dispersion solide medicinale
|
JP2004509739A
(ja)
*
|
2000-09-27 |
2004-04-02 |
ベリオン インコーポレイテッド |
即時水溶解性カプセルおよびその製法
|
US6579521B2
(en)
|
2000-10-20 |
2003-06-17 |
Chiron Corporation |
Methods of therapy for HIV infection
|
WO2002035991A2
(en)
|
2000-10-30 |
2002-05-10 |
The Board Of Regents, The University Of Texas System |
Spherical particles produced by a hot-melt extrusion/spheronization process
|
GB0026593D0
(en)
|
2000-10-31 |
2000-12-13 |
Quadrant Holdings Cambridge |
Derivatised carbohydrates and their use in solid delivery systems
|
AU2002212102A1
(en)
|
2000-11-08 |
2002-05-21 |
Aeromatic-Fielder Ag |
A process for production of particles for pharmaceutical compositions having increased bioavailability
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
NZ525726A
(en)
|
2000-11-09 |
2004-10-29 |
Astrazeneca Ab |
Oral pharmaceutical composition containing a block copolymer
|
US6733781B2
(en)
*
|
2000-12-06 |
2004-05-11 |
Wyeth |
Fast dissolving tablet
|
GB0029843D0
(en)
|
2000-12-07 |
2001-01-24 |
Univ Belfast |
Drug delivery system
|
US20050175687A1
(en)
|
2001-01-30 |
2005-08-11 |
Mcallister Stephen M. |
Pharmaceutical formulations
|
US7883721B2
(en)
|
2001-01-30 |
2011-02-08 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
US7842308B2
(en)
|
2001-01-30 |
2010-11-30 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
WO2002064121A1
(en)
|
2001-02-13 |
2002-08-22 |
Astrazeneca Ab |
Novel modified released formulation
|
GB0104752D0
(en)
|
2001-02-27 |
2001-04-18 |
Astrazeneca Ab |
Pharmaceutical compositions
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
CA2444116C
(en)
|
2001-05-03 |
2009-01-20 |
F. Hoffmann-La Roche Ag |
Pharmaceutical dosage form of amorphous nelfinavir mesylate
|
DK1387842T3
(da)
|
2001-05-11 |
2009-08-10 |
Tibotec Pharm Ltd |
Bredspektrede 2-amino-benzoxazolsulfonamid-HIV-protease-inhibitorer
|
US6730319B2
(en)
*
|
2001-06-06 |
2004-05-04 |
Hoffmann-La Roche Inc. |
Pharmaceutical compositions having depressed melting points
|
EP1269994A3
(en)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
|
TNSN03137A1
(en)
*
|
2001-06-22 |
2005-12-23 |
Pfizer Prod Inc |
PHARMACEUTICAL COMPOSITIONS COMPRISING LOW SOLUBILITY AND / OR ACID SENSITIVE DRUGS AND NEUTRALIZED ACID POLYMERS.
|
ITMI20011338A1
(it)
*
|
2001-06-26 |
2002-12-26 |
Farmatron Ltd |
Composizioni farmaceutiche orali a rilascio immediato del principio attivo
|
ITMI20011337A1
(it)
|
2001-06-26 |
2002-12-26 |
Farmatron Ltd |
Composizioni farmaceutiche orali a rilascio modificato del principio attivo
|
US20030044474A1
(en)
|
2001-08-03 |
2003-03-06 |
Shaklee Corporation |
High molecular weight, lipophilic, orally ingestible bioactive agents in formulations having improved bioavailability
|
JP4644397B2
(ja)
*
|
2001-09-05 |
2011-03-02 |
信越化学工業株式会社 |
難溶性薬物を含む医薬用固形製剤の製造方法
|
US6982094B2
(en)
|
2001-09-28 |
2006-01-03 |
Mcneil-Ppc, Inc. |
Systems, methods and apparatuses for manufacturing dosage forms
|
EP1429746B1
(en)
|
2001-09-28 |
2008-08-13 |
McNEIL-PPC, INC. |
Dosage forms having an inner core and outer shell
|
US7122143B2
(en)
|
2001-09-28 |
2006-10-17 |
Mcneil-Ppc, Inc. |
Methods for manufacturing dosage forms
|
US7491407B2
(en)
*
|
2001-10-31 |
2009-02-17 |
North Carolina State University |
Fiber-based nano drug delivery systems (NDDS)
|
JP2003146869A
(ja)
*
|
2001-11-14 |
2003-05-21 |
Scg:Kk |
口腔内崩壊型固形製剤及びその製造方法
|
US6524606B1
(en)
|
2001-11-16 |
2003-02-25 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters containing amine groups
|
EP1509204A4
(en)
|
2001-11-29 |
2005-07-13 |
Rettenmaier & Soehne Gmbh & Co |
AGGLOMERATED PARTICLES WITH AN ACTIVE SUBSTANCE PREPARED WITH MELTED MICROCRYSTALLINE CELLULOSE
|
US20030206978A1
(en)
|
2001-11-29 |
2003-11-06 |
Bob Sherwood |
Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
|
CA2474958A1
(en)
|
2002-02-01 |
2003-08-07 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
|
KR100664822B1
(ko)
|
2002-02-01 |
2007-01-04 |
화이자 프로덕츠 인코포레이티드 |
변형된 분무-건조 장치를 이용한 균질한 분무-건조된 고체비결정성 약물 분산액의 제조 방법
|
US20030203027A1
(en)
|
2002-04-26 |
2003-10-30 |
Ethicon, Inc. |
Coating technique for deposition of drug substance on a substrate
|
AU2003246351B2
(en)
|
2002-07-04 |
2009-02-19 |
Janssen Pharmaceutica N.V. |
Solid dispersions comprising two different polymer matrixes
|
US20040062778A1
(en)
*
|
2002-09-26 |
2004-04-01 |
Adi Shefer |
Surface dissolution and/or bulk erosion controlled release compositions and devices
|
DE10247037A1
(de)
|
2002-10-09 |
2004-04-22 |
Abbott Gmbh & Co. Kg |
Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
|
US6872799B2
(en)
|
2002-12-18 |
2005-03-29 |
Ethicon, Inc. |
Functionalized polymers for medical applications
|
ITMI20022748A1
(it)
|
2002-12-23 |
2004-06-24 |
Eurand Int |
Dispersioni solide stabilizzate di farmaco in un carrier organico e procedimento per la loro preparazione.
|
DE10304403A1
(de)
*
|
2003-01-28 |
2004-08-05 |
Röhm GmbH & Co. KG |
Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung
|
ATE454886T1
(de)
*
|
2003-03-26 |
2010-01-15 |
Egalet As |
Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen
|
US20040208928A1
(en)
|
2003-04-15 |
2004-10-21 |
Animal Technology Institute Taiwan |
Method for preparing an orally administrable formulation for controlled release
|
JP2004339162A
(ja)
|
2003-05-16 |
2004-12-02 |
Shin Etsu Chem Co Ltd |
難溶性薬物を含む医薬用固形製剤とその製造方法
|
DE10325989A1
(de)
|
2003-06-07 |
2005-01-05 |
Glatt Gmbh |
Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
|
WO2005000237A2
(en)
|
2003-06-25 |
2005-01-06 |
University Of Tennessee Research Foundation |
Granules containing biologically active substances
|
US7785512B1
(en)
|
2003-07-31 |
2010-08-31 |
Advanced Cardiovascular Systems, Inc. |
Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices
|
US7645474B1
(en)
*
|
2003-07-31 |
2010-01-12 |
Advanced Cardiovascular Systems, Inc. |
Method and system of purifying polymers for use with implantable medical devices
|
US20070122482A1
(en)
|
2003-10-03 |
2007-05-31 |
Per Holm |
Method for preparing modified release pharmaceutical compositions
|
EP1674083B1
(en)
|
2003-10-15 |
2018-08-01 |
Fuji Chemical Industry Co., Ltd. |
Tablet quickly disintegrating in oral cavity
|
US8349361B2
(en)
*
|
2003-10-15 |
2013-01-08 |
Fuji Chemical Industry Co., Ltd. |
Composition for rapid disintegrating tablet in oral cavity
|
US7413690B1
(en)
|
2003-10-29 |
2008-08-19 |
The University Of Mississippi |
Process and apparatus for producing spherical pellets using molten solid matrices
|
CN1878540B
(zh)
|
2003-12-15 |
2012-02-29 |
科学与工业研究委员会 |
含pH敏感性聚合物的掩味的药物组合物
|
US20050281876A1
(en)
|
2004-06-18 |
2005-12-22 |
Shun-Por Li |
Solid dosage form for acid-labile active ingredient
|
DE102004040104A1
(de)
|
2004-08-18 |
2006-02-23 |
Basf Ag |
Verwendung von amphiphilen Copolymerisaten als Solubilisatoren
|
GB0501835D0
(en)
|
2005-01-28 |
2005-03-09 |
Unilever Plc |
Improvements relating to spray dried compositions
|
US20090104269A1
(en)
*
|
2005-02-11 |
2009-04-23 |
Brian Graham |
Nanoformulations
|
CA2598762A1
(en)
|
2005-02-25 |
2006-08-31 |
F. Hoffmann-La Roche Ag |
Tablets with improved drug substance dispersibility
|
MX2007014587A
(es)
|
2005-06-03 |
2008-02-05 |
Horizon Science Pty Ltd |
Sistemas de distribucion.
|
WO2007002041A2
(en)
|
2005-06-21 |
2007-01-04 |
Foster Corporation |
Drug-filled polymer films
|
JP2009502841A
(ja)
|
2005-07-26 |
2009-01-29 |
グラクソ グループ リミテッド |
脂質をベースにした製剤の腸溶性ポリマー中へのカプセル化
|
US20100137455A1
(en)
|
2005-08-11 |
2010-06-03 |
Basf Se |
N-vinylcaprolactam-based copolymers and the use thereof as solubilizers
|
US20080248107A1
(en)
|
2005-08-24 |
2008-10-09 |
Rubicon Research Pvt. Ltd. |
Controlled Release Formulation
|
US20070077305A1
(en)
*
|
2005-10-03 |
2007-04-05 |
Le Tien C |
Biocompatible polymeric matrix and preparation thereof
|
WO2007050631A2
(en)
|
2005-10-25 |
2007-05-03 |
Cima Labs Inc. |
Dosage form with coated active
|
ITMI20052461A1
(it)
*
|
2005-12-22 |
2007-06-23 |
Univ Degli Studi Milano |
Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
|
US20080305168A1
(en)
|
2006-02-10 |
2008-12-11 |
Kyo-Tae Moon |
In-Situ Melting and Gelling Tablet Composition For Oral Care
|
US7771632B2
(en)
|
2006-05-15 |
2010-08-10 |
American Leistritz Extruder Corp. |
Continuous melt spheronization apparatus and process for the production of pharmaceutical pellets
|
WO2007141182A2
(de)
|
2006-06-07 |
2007-12-13 |
Basf Se |
Verwendung von vinylacetat-sulfonat-copolymeren als solubilisatoren für in wasser schwerlösliche verbindungen
|
US8343548B2
(en)
*
|
2006-08-08 |
2013-01-01 |
Shin-Etsu Chemical Co., Ltd. |
Solid dosage form comprising solid dispersion
|
US7923026B2
(en)
*
|
2006-10-20 |
2011-04-12 |
Solvay Pharmaceuticals B.V. |
Embedded micellar nanoparticles
|
WO2008065502A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
|
DE102007009242A1
(de)
|
2007-02-22 |
2008-09-18 |
Evonik Röhm Gmbh |
Pellets mit magensaftresistenter Wirkstoff-Matix
|
US20100204425A1
(en)
|
2007-07-26 |
2010-08-12 |
Basf Se |
Process for preparing copolymers obtained by graft polymerization in solution and based on polyethers in solid form
|
EP2022805A3
(en)
*
|
2007-08-03 |
2009-02-25 |
Basf Se |
Copolymers based on N-vinyllactams and olefins as their use as solubilizers for slightly water-soluble compounds
|
KR101564472B1
(ko)
|
2007-10-11 |
2015-10-29 |
필립모리스 프로덕츠 에스.에이. |
무연 담배 제품
|
CA2718255C
(en)
*
|
2008-03-11 |
2016-08-23 |
Aska Pharmaceutical Co., Ltd. |
Solid dispersion and pharmaceutical composition of the same, and production processes thereof
|
AR071375A1
(es)
|
2008-04-22 |
2010-06-16 |
Solvay Pharm Gmbh |
Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
|
WO2010017053A1
(en)
|
2008-08-06 |
2010-02-11 |
Isp Investments, Inc. |
Solid excipient compositions
|
GB0815852D0
(en)
|
2008-09-01 |
2008-10-08 |
Unilever Plc |
Improvements relating to pharmaceutical compositions
|
ES2592808T3
(es)
*
|
2008-09-15 |
2016-12-01 |
Paladin Labs Inc. |
Micropartículas a base de almidón para la liberación de agentes dispuestos en su interior
|
JP2012506904A
(ja)
|
2008-10-28 |
2012-03-22 |
エージェンシー フォー サイエンス,テクノロジー アンド リサーチ |
難水溶性成分のためのメソ多孔性材料賦形剤
|
US8715715B2
(en)
|
2008-11-03 |
2014-05-06 |
Nal Pharmaceuticals Ltd. |
Dosage form for insertion into the mouth
|
US20100166857A1
(en)
|
2008-12-30 |
2010-07-01 |
Dong Yan |
Pharmaceutical dosage forms and methods of manufacturing same
|
CN101444494B
(zh)
|
2008-12-31 |
2011-03-30 |
江苏大学 |
难溶性药物高效长效缓释制剂及其制法
|
EP2393484A1
(en)
|
2009-02-06 |
2011-12-14 |
Egalet Ltd. |
Immediate release composition resistant to abuse by intake of alcohol
|
EP2311435A1
(en)
|
2009-10-07 |
2011-04-20 |
LEK Pharmaceuticals d.d. |
Pharmaceutical composition comprising poorly soluble active ingredient and hyperbranched polymer
|
WO2011090724A2
(en)
|
2009-12-29 |
2011-07-28 |
Impax Laboratories, Inc. |
Gastroretentive solid oral dosage forms with lipid-based low-density excipient
|
EP2552402B1
(en)
|
2010-03-26 |
2016-11-23 |
Dow Global Technologies LLC |
Multilayer melt-extruded film
|
US20110288181A1
(en)
|
2010-05-21 |
2011-11-24 |
Basf Se |
Preparations of biologically active substances with enlarged surface based on amphiphilic copolymers
|
CN103153343B
(zh)
|
2010-06-14 |
2015-02-11 |
陶氏环球技术有限责任公司 |
具有提高的醋酸酯和琥珀酸酯取代的醋酸羟丙基甲基纤维素琥珀酸酯
|